Combined modality treatment with a weekly brief chemotherapy (ACOP-B) followed by locoregional radiotherapy in localized-stage intermediate- to high-grade non-Hodgkin's lymphoma

Annals of Oncology

Volumn 7, Issue 9, 1996, Pages 919-924

  Freilone, R ^a,k   Botto, B ^a   Vitolo, U ^a   Bertini, M ^a   Audisio, E ^a   Calvi, R ^a   Cucchi, M ^b   De Crescenzo, A ^a   Gallamini, A ^c   Ghio, R ^d   Griso, L ^e   Levis, A ^f   Massara, G ^g   Orsucci, L ^a   Ricardi, U ^h   Rota Scalabrini, D ⁱ   Salvi, F ^f   Seconde, V ^j   Resegotti, L ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b Ospedale Generale   (Italy)

^c S CROCE E CARLE HOSPITAL   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e Ospedale E Agnelti   (Italy)

^f C Arrigo Children's Hospital   (Italy)

^g Ospedale Civile   (Italy)

^h UNIVERSITY OF TURIN   (Italy)

ⁱ MAURIZIANO HOSPITAL   (Italy)

^j GALLIERA HOSPITAL   (Italy)

^k Ospedale Galliera ^*  (Italy)

more..

Author keywords

chemotherapy plus radiotherapy; intermediate to high grade NHL; localized

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 12644255692     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010794     Document Type: Article

References (33)

1. Chabner BA, Johnson RE, Young RE et al. Sequental non surgical and surgical staging of non-Hodgkiris lymphoma. Cancer 1978; 42: 922-5.
2. The Non-Hodgkin's Lymphoma Classification Project. National Cancer Institute sponsored study of non-Hodgkin's lymphoma. Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112-35.
3. Levitt SH, Lee CK, Bloomfield CD et al. The role of radiation therapy in the treatment of the early stage large cell lymphoma. Hemato Oncol 1985;3:33-7.
4. Kaminski MS, Coleman CN, Colby TV et al. Factors predicting survival in adults with stage I and II large cell lymphoma treated with primary radiation therapy. Ann Intern Med 1986; 104: 747-56.
5. Bitran JD, Kinzie J, Sweet DL et al. Survival of patients with localized histiocytic lymphoma. Cancer 1977; 39: 342-6.
6. Connors JM, Klimo P, Fairey RN et al. Brief chemotherapy and involved field radiation therapy for limited stage histologically aggressive lymphoma. Ann Intern Med 1987; 107: 25-30.
7. Bonadonna G, Lattuada A, Monfardini S et al. Combined radiotherapy-chemotherapy in localized non-Hodgkin's lymphomas: 5-Year result of a randomized study. In Jones SE, Salmon SE (eds): Adjuvant Therapy of Cancer II. New York: Grune & Stratton 1979; 145-63.
8. Landberg TG, Hakansson LG, Moller TR et al. CVP-remission-manteinance in stage I or II non-Hodgkin's lymphoma. Cancer 1979; 44: 831-8.
9. Nissen NI, Ersboll J, Hansen HA et al. A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphomas. Cancer 1983; 52: 1-7.
10. Mauch P, Leonard R, Skarin A et al. Improved survival following combined radiation therapy and chemotherapy for unfavorable prognosis stage I-II non-Hodgkin's lymphomas. J Clin Oncol 1985; 3: 1301-8.
11. Miller TP, Jones SE. Initial chemotherapy for clinically localized lymphoma of unfavorable histology. Blood 1983; 62: 413-8.
12. Jones SE, Miller TP, Connors JM. Long term follow up analysis for prognostic factor for patients with limited stage diffuse large cell lymphoma treated with initial chemotherapy with or without adjuvant radiotherapy. J Clin Oncol 1989; 7: 1186-91.
13. Connors JM, Fairey R, Klimo P et al. ACOP-B: 6 week chemotherapy and involved field radioterapy (IFRT) for limited stage large cell lymphoma. Initial result. Proc Am Soc Clin Oncol 1987; 7: 224 (Abstr).
14. Kaplan EL, Meier P. Non-parametric estimation from incomplete information. J Am Stat Assoc 1958; 53: 457-81.
15. Breslow N. Covariance analyse of censored survival data. Biometrics 1974; 30: 89-99.
16. Klimo P, Connor JM. MACOP-B chemotherapy for the treatment of advanced diffuse large cell lymphoma. Ann Intern Med 1985; 102: 596-602.
17. Tondini C, Zanini M, Lombardi F et al. Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas. J Clin Oncol 1993; 11: 720-5.
18. Lambertenghi Delillers G, Butti C, Baldini L et al. A cooperative study of epirubicine with cyclophosphamide, vincristine and prednisone (CEOP) in non-Hodgkin's lymphomas. Haematologica 1995; 80: 318-24.
19. Gaynor ER, Fisher RI. Conventional treatment for intermediate- and high-grade non-Hodgkin's lymphomas. Forum 1995; 5:607-16.
20. Gunk JH, Kim K, Earle J et al. An ECOG randomized phase III trial of CHOP vs. CHOP + radiotherapy (XRT) for intermediate grade early stage non-Hodgkin's lymphomas. Proc Am Soc Clin Oncol 1995; 14: 391 (Abstr).
21. Miller TP, Dalberg S, Cassady JR et al. Three cycles of CHOP (3) plus radiotherapy (RT) is superior to eight cycles of CHOP (8) alone for localized intermediate- and high-grade NHL: Southwest Oncology Group Study. Proc Am Soc Clin Oncol 1996; 15: 411 (Abstr).
22. Miller TP, Dalberg S, Cassady JR et al. Superiority of a brief course of CHOP plus radiotherapy (RT) over CHOP alone in localized unfavorable non-Hodgkin's lymphomas (NHL) is seen in lowest subgroups: A Southwest Oncology Group Study. Ann Oncol 1996; 7 (Suppl 3): 23.
23. Sweet DL, Kinzie J, Gaeke ME et al. Survival of patients with localized diffuse histiocytic lymphoma. Blood 1981; 58: 1218-23.
24. Vokes EE, Ultmann JE, Golomb HM et al. Long term survival of patients with localized diffuse histiocytic lymphoma. J Clin Oncol 1985; 3: 1309-17.
25. O'Connel MJ, Harrington DP, Earle JD et al. Chemotherapy followed by consolidation radiation therapy for the treatment of clinical stage II aggressive histologic type non-Hodgkin's lymphomas. Cancer 1988; 61: 1754-8.
26. Lopez-Guillermo EJ, Martinez-Frances A, Bosch F et al. Presenting features history, and prognosyic factors in localized non-Hodgkin's lymphomas: Analysis of 117 cases from a single institution. Eur J Haematol 1995; 55: 217-22.
27. Desamblens B, Colombat Ph, Francois S et al. Localized nodal aggressive NHL. Analysis of 224 patients treated by the two GOELAMS 02 & 03 trials. Br J Haematol 1996; 93 (Suppl 2): 366 (Abstr).
28. Velasquez WS, Fuller LM, Jagannath S et al. Stages I and II diffuse large cell lymphomas: Prognostic factors and long term results with CHOP-bleo and radiotherapy. Blood 1991; 77: 942-7.
29. Tepperman BS, Gosporadowicz MK, Bush PS et al. Non-Hodgkin's lymphoma of the testis. Radiology 1982; 142: 203-8.
30. Connors JM, Klimo P, Voss N et al. Testicular lymphoma: Improved outcome with early brief chemotherapy. J Clin Oncol 1988; 6: 776-81.
31. Martenson JA, Burkirk SJ, Ilstrup DM et al. Pattern of failure in primary testicular non-Hodgkin's lymphoma. J Clin Oncol 1988; 6: 297-302.
32. Touroutoglou N, Dimopoulos A, Younes A et al. Testicular lymphoma: Late relapses and poor outcome despite doxorubicin-based therapy. J Clin Oncol 1995; 13: 1361-7.
33. Carbone PP, Kaplan KS, Musshoff H et al. Report of the commitee on Hodgkin's disease, staging classification. Cancer Res 1971; 31: 1860-1.